NCT03595852 is a NA clinical trial of Cefazolin in Surgical Site Infection, sponsored by University of Rwanda.

Who is sponsoring NCT03595852?

NCT03595852 is sponsored by University of Rwanda.

What drugs are being tested in NCT03595852?

Interventions in NCT03595852: Cefazolin, Placebos.

What condition does NCT03595852 study?

NCT03595852 studies Surgical Site Infection.

Is NCT03595852 still recruiting?

NCT03595852 is currently completed. Last updated 4 September 2019.

Last reviewed 2019-09-04 · How we verify

NCT03595852

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antibiotic Prophylaxis in Clean Surgery. Impact on Surgical Site Infection

Completed NA Last updated 4 September 2019

What this trial tests

NA trial testing Cefazolin in Surgical Site Infection in 138 participants. Completed in 15 March 2019.

Timeline

1 March 2018

Primary endpoint
1 September 2018

15 March 2019

Quick facts

Lead sponsor	University of Rwanda
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	138
Start date	1 March 2018
Primary completion	1 September 2018
Estimated completion	15 March 2019
Sites	1 location across Rwanda

Drugs / interventions tested

Cefazolin (CEFAZOLIN) — full drug profile →
Placebos — full drug profile →

Conditions studied

Surgical Site Infection — all drugs for Surgical Site Infection →

Sponsor

University of Rwanda

Who can join

Eligibility, any sex, with Surgical Site Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized control study of antibiotic uses in clean non prosthetic surgeries. One group will be given antibiotic prophylaxis, other will receive a placebo. The primary outcome will be the rate of surgical site infection in 2 groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cefazolin

Trials testing the same drug.

NCT06567808 — Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial · Phase 4 · not yet recruiting
NCT07478874 — Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic · NA · completed
NCT07111702 — Prophylactic Antibiotics in Groin Hernioplasty · NA · completed
NCT05647993 — Comparing of Cefazolin Plus Azithromycin Versus Cefazolin in Prevention of Febrile Morbidity After Emergency Cesarean De · NA · completed
NCT05137119 — Staphylococcus Aureus Network Adaptive Platform Trial · Phase 4 · recruiting

Other recruiting trials for Surgical Site Infection

Currently open trials in the same condition.

NCT07501897 — Investigating the Impact of Cold Atmospheric Plasma Treatment on Wound Healing at Cannulation Sites in Patients Followin · NA · recruiting
NCT07311395 — Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section · NA · recruiting
NCT06649890 — A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™ · NA · recruiting
NCT07005635 — The Effects of Different Time Reminder On Surgical Hand Scrubing · NA · active not recruiting
NCT07049614 — Comparative Study of Postoperative Surgical Site Infections in Diabetic and Non-Diabetic Patients · active not recruiting

Other University of Rwanda trials

Trials by the same sponsor.

NCT06711848 — Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer · NA · not yet recruiting
NCT06959134 — Community Health Workers-led Multicomponent Intervention for Hypertension Control in Rwanda · NA · completed
NCT04912414 — Brief Family Therapy (BFT) for the Treatment of Psychosomatic Symptoms in Rwanda · NA · completed
NCT06768502 — Effectiveness of Community-based Approach in Reducing the Intimate Partner Violence (IPV) Exposure and Outcome · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03595852 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rwanda
Last refreshed: 4 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing